Inventor · disambiguated record
Bruce A. Littlefield
Also filed as: LITTLEFIELD BRUCE A
8 granted patents·10 pending applications·556 citations·filing 1992–2018
91Inventor score
Top patents by PatentIndex Score
18 records- 0196US7470720B2Methods and compositions for use in treating cancerEISAI R&D MAN CO LTD·Filed 2003·Granted Dec 30, 2008·64 cites·24 claims
- 0296US6653341B1Methods and compositions for use in treating cancerEISAI CO LTD·Filed 2002·Granted Nov 25, 2003·93 cites·33 claims
- 0395US6469182B1Intermediates in the preparation of macrocyclic analogsEISAI CO LTD·Filed 2001·Granted Oct 22, 2002·89 cites·1 claims
- 0495US6214865B1Macrocyclic analogs and methods of their use and preparationEISAI CO LTD·Filed 1999·Granted Apr 10, 2001·168 cites·21 claims
- 0594US8097648B2Methods and compositions for use in treating cancerLITTLEFIELD BRUCE A·Filed 2005·Granted Jan 17, 2012·58 cites·5 claims
- 0694US6365759B1Intermediate compounds for preparing macrocylcic analogsEISAI CO LTD·Filed 2000·Granted Apr 2, 2002·62 cites·4 claims
- 0764US5340833AUrokinase inhibitorsEISAI CO LTD·Filed 1992·Granted Aug 23, 1994·22 cites·15 claims
- 0863US2009104285A1Methods and Compositions for Use in Treating CancerLITTLEFIELD BRUCE A·Filed 2008·Application pending·0 cites
- 0956US2010190843A1Tubulin Isotype Screening in Cancer Therapy Using Halichondrin B AnalogsEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 1052US2006154312A1Tubulin isotype screening in cancer therapy using halichondrin B analogsAGOULNIK SERGEI·Filed 2005·Application pending·0 cites
- 1149US2020129473A1Use of eribulin and cyclin dependent kinase inhibitors in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 1249US2007196418A1Drug delivery methods and devicesLEWIS MICHAEL·Filed 2004·Application pending·0 cites
- 1345US2019282541A1Use of eribulin and histone deacetylase inhibitors in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 1439US2006134602A1Methods of identifying cytotoxic effects in quiescent cellsLITTLEFIELD BRUCE A·Filed 2005·Application pending·0 cites
- 1536US2006148014A1Tubulin isotype screening in cancer therapy using hemiasterlin analogsAGOULNIK SERGEI·Filed 2005·Application pending·0 cites
- 1633US9637795B2Methods and compositions for predicting response to eribulinAGOULNIK SERGEI I·Filed 2012·Granted May 2, 2017·0 cites·20 claims
- 1733US2017071903A1Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
- 1832US2017100367A1Use of eribulin in the treatment of cancerLITTLEFIELD BRUCE A·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce A. Littlefield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →